vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and UL Solutions Inc. (ULS). Click either name above to swap in a different company.
UL Solutions Inc. is the larger business by last-quarter revenue ($789.0M vs $493.8M, roughly 1.6× Pediatrix Medical Group, Inc.). UL Solutions Inc. runs the higher net margin — 8.5% vs 6.8%, a 1.7% gap on every dollar of revenue. On growth, UL Solutions Inc. posted the faster year-over-year revenue change (6.8% vs -1.7%). Over the past eight quarters, UL Solutions Inc.'s revenue compounded faster (8.5% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
The UL enterprise is a global private safety company headquartered in Northbrook, Illinois, composed of three organizations, UL Research Institutes, UL Standards & Engagement and UL Solutions.
MD vs ULS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $789.0M |
| Net Profit | $33.7M | $67.0M |
| Gross Margin | — | 49.7% |
| Operating Margin | 9.9% | 15.0% |
| Net Margin | 6.8% | 8.5% |
| Revenue YoY | -1.7% | 6.8% |
| Net Profit YoY | 10.5% | -17.3% |
| EPS (diluted) | $0.40 | $0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $789.0M | ||
| Q3 25 | $492.9M | $783.0M | ||
| Q2 25 | $468.8M | $776.0M | ||
| Q1 25 | $458.4M | $705.0M | ||
| Q4 24 | $502.4M | $739.0M | ||
| Q3 24 | $511.2M | $731.0M | ||
| Q2 24 | $504.3M | $730.0M | ||
| Q1 24 | $495.1M | $670.0M |
| Q4 25 | $33.7M | $67.0M | ||
| Q3 25 | $71.7M | $100.0M | ||
| Q2 25 | $39.3M | $91.0M | ||
| Q1 25 | $20.7M | $67.0M | ||
| Q4 24 | $30.5M | $81.0M | ||
| Q3 24 | $19.4M | $88.0M | ||
| Q2 24 | $-153.0M | $101.0M | ||
| Q1 24 | $4.0M | $56.0M |
| Q4 25 | — | 49.7% | ||
| Q3 25 | — | 50.3% | ||
| Q2 25 | — | 49.4% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | 47.4% | ||
| Q3 24 | — | 49.0% | ||
| Q2 24 | — | 50.1% | ||
| Q1 24 | — | 47.6% |
| Q4 25 | 9.9% | 15.0% | ||
| Q3 25 | 13.8% | 19.9% | ||
| Q2 25 | 12.8% | 17.9% | ||
| Q1 25 | 7.0% | 15.5% | ||
| Q4 24 | 7.8% | 15.6% | ||
| Q3 24 | 6.6% | 17.8% | ||
| Q2 24 | -31.3% | 17.3% | ||
| Q1 24 | 3.2% | 13.6% |
| Q4 25 | 6.8% | 8.5% | ||
| Q3 25 | 14.5% | 12.8% | ||
| Q2 25 | 8.4% | 11.7% | ||
| Q1 25 | 4.5% | 9.5% | ||
| Q4 24 | 6.1% | 11.0% | ||
| Q3 24 | 3.8% | 12.0% | ||
| Q2 24 | -30.3% | 13.8% | ||
| Q1 24 | 0.8% | 8.4% |
| Q4 25 | $0.40 | $0.33 | ||
| Q3 25 | $0.84 | $0.49 | ||
| Q2 25 | $0.46 | $0.45 | ||
| Q1 25 | $0.24 | $0.33 | ||
| Q4 24 | $0.37 | $0.40 | ||
| Q3 24 | $0.23 | $0.44 | ||
| Q2 24 | $-1.84 | $0.50 | ||
| Q1 24 | $0.05 | $0.28 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $295.0M |
| Total DebtLower is stronger | $570.5M | $491.0M |
| Stockholders' EquityBook value | $865.9M | $1.3B |
| Total Assets | $2.2B | $2.9B |
| Debt / EquityLower = less leverage | 0.66× | 0.39× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $295.0M | ||
| Q3 25 | $340.1M | $255.0M | ||
| Q2 25 | $224.7M | $272.0M | ||
| Q1 25 | $99.0M | $267.0M | ||
| Q4 24 | $229.9M | $298.0M | ||
| Q3 24 | $103.8M | $327.0M | ||
| Q2 24 | $19.4M | $295.0M | ||
| Q1 24 | $8.0M | $344.0M |
| Q4 25 | $570.5M | $491.0M | ||
| Q3 25 | $577.2M | $544.0M | ||
| Q2 25 | $583.9M | $608.0M | ||
| Q1 25 | $590.5M | $653.0M | ||
| Q4 24 | $597.1M | $742.0M | ||
| Q3 24 | — | $797.0M | ||
| Q2 24 | — | $810.0M | ||
| Q1 24 | — | $879.0M |
| Q4 25 | $865.9M | $1.3B | ||
| Q3 25 | $890.7M | $1.2B | ||
| Q2 25 | $833.8M | $1.1B | ||
| Q1 25 | $789.2M | $970.0M | ||
| Q4 24 | $764.9M | $904.0M | ||
| Q3 24 | $732.5M | $872.0M | ||
| Q2 24 | $706.5M | $769.0M | ||
| Q1 24 | $856.2M | $671.0M |
| Q4 25 | $2.2B | $2.9B | ||
| Q3 25 | $2.2B | $2.9B | ||
| Q2 25 | $2.1B | $2.9B | ||
| Q1 25 | $2.0B | $2.9B | ||
| Q4 24 | $2.2B | $2.8B | ||
| Q3 24 | $2.1B | $2.9B | ||
| Q2 24 | $2.0B | $2.7B | ||
| Q1 24 | $2.2B | $2.8B |
| Q4 25 | 0.66× | 0.39× | ||
| Q3 25 | 0.65× | 0.46× | ||
| Q2 25 | 0.70× | 0.56× | ||
| Q1 25 | 0.75× | 0.67× | ||
| Q4 24 | 0.78× | 0.82× | ||
| Q3 24 | — | 0.91× | ||
| Q2 24 | — | 1.05× | ||
| Q1 24 | — | 1.31× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $144.0M |
| Free Cash FlowOCF − Capex | — | $86.0M |
| FCF MarginFCF / Revenue | — | 10.9% |
| Capex IntensityCapex / Revenue | — | 7.4% |
| Cash ConversionOCF / Net Profit | 3.39× | 2.15× |
| TTM Free Cash FlowTrailing 4 quarters | — | $403.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $144.0M | ||
| Q3 25 | $137.3M | $155.0M | ||
| Q2 25 | $137.2M | $147.0M | ||
| Q1 25 | $-117.5M | $154.0M | ||
| Q4 24 | $133.0M | $130.0M | ||
| Q3 24 | $91.8M | $150.0M | ||
| Q2 24 | $107.0M | $103.0M | ||
| Q1 24 | $-125.2M | $141.0M |
| Q4 25 | — | $86.0M | ||
| Q3 25 | — | $109.0M | ||
| Q2 25 | — | $105.0M | ||
| Q1 25 | — | $103.0M | ||
| Q4 24 | — | $72.0M | ||
| Q3 24 | — | $84.0M | ||
| Q2 24 | — | $47.0M | ||
| Q1 24 | — | $84.0M |
| Q4 25 | — | 10.9% | ||
| Q3 25 | — | 13.9% | ||
| Q2 25 | — | 13.5% | ||
| Q1 25 | — | 14.6% | ||
| Q4 24 | — | 9.7% | ||
| Q3 24 | — | 11.5% | ||
| Q2 24 | — | 6.4% | ||
| Q1 24 | — | 12.5% |
| Q4 25 | — | 7.4% | ||
| Q3 25 | — | 5.9% | ||
| Q2 25 | — | 5.4% | ||
| Q1 25 | — | 7.2% | ||
| Q4 24 | — | 7.8% | ||
| Q3 24 | — | 9.0% | ||
| Q2 24 | — | 7.7% | ||
| Q1 24 | — | 8.5% |
| Q4 25 | 3.39× | 2.15× | ||
| Q3 25 | 1.91× | 1.55× | ||
| Q2 25 | 3.49× | 1.62× | ||
| Q1 25 | -5.66× | 2.30× | ||
| Q4 24 | 4.36× | 1.60× | ||
| Q3 24 | 4.72× | 1.70× | ||
| Q2 24 | — | 1.02× | ||
| Q1 24 | -31.03× | 2.52× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
ULS
| Industrial | $352.0M | 45% |
| Ongoing Certification Services | $259.0M | 33% |
| Software And Advisory | $102.0M | 13% |
| Software | $75.0M | 10% |
